Industries > Pharma > Global Live Vaccines Market Forecast 2020-2030

Global Live Vaccines Market Forecast 2020-2030

Bacterial, Viral, Oral Polio Vaccine, Measles, Rotavirus, Tuberculosis, Yellow Fever, Oral, Injectable, End Users, Hospitals, Specialty Clinics, Others PLUS analysis on leading companies in the Live Vaccines Market

PUBLISHED: 12 March 2020
PAGES: 213
PRODUCT CODE: PHA0725
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1

covid-19

The global live vaccines market was valued at $10,423.4 mn in 2019 and is anticipated to surpass $ 20,020 mn by 2030. In 2019, the North American segment held 39% of the global live vaccines market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 213-page report you will receive 138 tables and 65 figures– all unavailable elsewhere.

The 213-page report provides clear detailed insight into the live vaccines market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Live Vaccines Market from 2020-2030

Global Live Vaccines Market Forecast 2020-2030

• Forecast of the Global Live Vaccines Market by Type of Product:
• Bacterial
• Viral

• Forecast of the Global Live Vaccines Market by Indication:
• Oral Polio Vaccine (OPV)
• Measles
• Rotavirus
• Tuberculosis
• Yellow Fever
• Others

• This report provides individual revenue forecasts to 2030 for these national markets:
• The US
• Canada
• Germany
• France
• UK
• Italy
• Spain
• Japan
• China
• India
• Brazil
• Mexico

• Our study discusses the selected leading companies that are the major players in the live vaccines market:
• AstraZeneca
• Bavarian Nordic A/S
• DAIICHI SANKYO COMPANY, LIMITED
• Emergent BioSolutions Inc.
• GlaxoSmithKline plc
• Inovio Pharmaceuticals, Inc.
• & Other Companies

• This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.

• This report discusses the SWOT & PEST Analyses of the live vaccines market.

Visiongain’s study is intended for anyone requiring commercial analyses for the live vaccines market. You find data, trends and predictions.

Buy our report today Global Live Vaccines Market Forecast 2020-2030: Bacterial, Viral, Oral Polio Vaccine, Measles, Rotavirus, Tuberculosis, Yellow Fever, Oral, Injectable, End Users, Hospitals, Specialty Clinics, Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Live Vaccines Market Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Global Live Vaccines Market Forecast 2020-2030


Latest Pharma news

Visiongain Publishes 3D Printing for Healthcare Market Report 2021-2031

The growing use of this technology in many applications such as transplantation, drug delivery, 3D printed organs, and many others in the healthcare industry is one of the key drivers in the global 3D Printing in Healthcare Market.

02 August 2021

READ

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

READ

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Categories